bioMérieux S.A.

EPA:BIM.PA

118.6 (EUR) • At close June 2, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q42012 Q22011 Q42011 Q22010 Q42010 Q22009 Q42009 Q22008 Q42008 Q22007 Q42007 Q22006 Q42006 Q22005 Q42005 Q2
Revenue 2,0781,901.91,904.61,770.11,931.11,6581,8021,574.21,6421,476.21,399.71,275.11,252.11,169.21,153.91,134.31,102.41,000.81,031.4933.2917.7780.7833.7754.2784.9784.9713.6713.6678.5678.5611.7611.7555.25555.25531.4531.4518.45518.45496.8496.8
Cost of Revenue 966.2856.8933.5854.5912.1744.9761.8667.5713.2668.8652.1574584.1534.9547.1529.3520.5482515.8459.6458.1395.8405.6357.7377.8377.8333.05333.05317.45317.45281.9281.9258.75258.75248.5248.5247.5247.5236.6236.6
Gross Profit 1,111.81,045.1971.1915.61,019913.11,040.2906.7928.8807.4747.6701.1668634.3606.8605581.9518.8515.6473.6459.6384.9428.1396.5407.1407.1380.55380.55361.05361.05329.8329.8296.5296.5282.9282.9270.95270.95260.2260.2
Gross Profit Ratio 0.5350.550.510.5170.5280.5510.5770.5760.5660.5470.5340.550.5340.5430.5260.5330.5280.5180.50.5080.5010.4930.5130.5260.5190.5190.5330.5330.5320.5320.5390.5390.5340.5340.5320.5320.5230.5230.5240.524
Reseach & Development Expenses 250.7240.8233.6226.5239.3207.3207.5181.5195.2200.5194.5178211.5156.2155.9148.5146.4125.5123115.910699.8101.190.785.585.576.0576.0574.674.671.571.566.3566.3565.965.964.864.865.3565.35
General & Administrative Expenses 00148.9146.1131.1122.1129.7112.4100.199.999.782.584.978.3156.478.379.679.685.977.976.864.963.45857.1557.1553.853.851.651.6-59.2157.9143143138.8138.8434340.9540.95
Selling & Marketing Expenses 00369.5356383.3318.2307.2266.3307282.3295.9271.7253.7226.2226.6220.9216.9185.2189176.4160.4150.9142.7140.5147.35147.35132.25132.25119.4119.4108.55108.5599.4599.4594.6594.6593.3593.3588.6588.65
SG&A 561.4536.2518.4502.1514.4440.3438.7379.6407.1382.2395.6354.2338.6304.5304.7299.2304.7264.8274.9254.3237.2215.8206.1198.5204.5204.5186.05186.0517117149.35266.45242.45242.45233.45233.45136.35136.35129.6129.6
Other Expenses 00000000000.83.7000000000000-13.05-13.05-10.35-10.35-11.35-11.35563-565.9-0.4-0.40.70.71.41.4-385.75-385.75
Operating Expenses 812.1777752728.6753.7647.6646.2561.1602.3582.7589.3528.5504.1459.2457.8447.1448.1378.1423.3374.5344.7305.5302.7277.6276.95276.95251.75251.75234.25234.25683.85-227.95308.4308.4300.05300.05202.55202.55-190.8-190.8
Operating Income 299.7268.1219.1187265.3265.5394345.6326.5224.7158.3172.6177.9185.6162.3172.4148.4149.4137.9122.113690.8137.4125117.5117.5122.65122.65122122101.85101.8593.4593.4583.583.574.774.769.469.4
Operating Income Ratio 0.1440.1410.1150.1060.1370.160.2190.220.1990.1520.1130.1350.1420.1590.1410.1520.1350.1490.1340.1310.1480.1160.1650.1660.150.150.1720.1720.180.180.1670.1670.1680.1680.1570.1570.1440.1440.140.14
Total Other Income Expenses Net -19.11.2-0.77.36.912.58.10.6-38.8-180.2-12.5-23-20-19.6-23.1-21-17.8-51.6-32.2-21.9-17.7-13.2-6.1-5.7-5.7-3.8-3.8-1.3-1.3-0.55-0.55-2.05-2.05-6.2-6.21.31.3-0.15-0.15
Income Before Tax 280.6269.3218.4194.3272.2278402.1346.2287.7206.7158.5160.1154.9165.6142.7149.3127.4131.686.389.9114.173.1124.2118.9111.8111.8118.85118.85120.7120.7101.3101.391.491.477.377.3767669.2569.25
Income Before Tax Ratio 0.1350.1420.1150.110.1410.1680.2230.220.1750.140.1130.1260.1240.1420.1240.1320.1160.1310.0840.0960.1240.0940.1490.1580.1420.1420.1670.1670.1780.1780.1660.1660.1650.1650.1450.1450.1470.1470.1390.139
Income Tax Expense 70.454.434.355.657.951.880.169.356.834.727.521.433.631.56.448.133.84635.230.729.222.539.538.944.744.738.638.640.740.727.227.225.7525.7527.5527.5523.323.324.224.2
Net Income 216.9215.3196161.6224.3228324277.1231.5172.9132.3140.5122.3134.2137101.193.485.750.959.684.550.484.679.767.267.279.179.1808074.174.165.6565.6549.7549.7552.752.745.0545.05
Net Income Ratio 0.1040.1130.1030.0910.1160.1380.180.1760.1410.1170.0950.110.0980.1150.1190.0890.0850.0860.0490.0640.0920.0650.1010.1060.0860.0860.1110.1110.1180.1180.1210.1210.1180.1180.0940.0940.1020.1020.0910.091
EPS 1.841.831.661.371.91.932.742.341.961.461.121.191.041.131.150.860.790.720.430.50.710.430.710.670.570.570.670.670.670.670.630.620.560.560.420.420.440.440.380.38
EPS Diluted 1.821.821.651.361.891.932.722.331.951.461.121.181.041.131.150.860.790.720.430.50.710.430.710.670.570.570.670.670.670.670.630.620.560.560.420.420.440.440.380.38
EBITDA 482.7408.8423383.1433.5408.2548.4456.9431.1316.5282.2265.9247.6258.4219.2252214.20205.10196.60175.50161.35161.35163.55163.55166.45166.45161.45102.55929276.676.675.9575.9569.2569.25
EBITDA Ratio 0.2320.2150.2220.2160.2240.2460.3040.290.2630.2140.2020.2090.1980.2210.190.2220.19400.19900.21400.21100.2060.2060.2290.2290.2450.2450.2160.1680.1660.1660.1440.1440.1460.1460.1390.139